Literature DB >> 4055779

Regulation of low density lipoprotein receptor synthesis in cultured luteinized human granulosa cells by human chorionic gonadotropin and 8-bromo-cyclic AMP.

T G Golos, J F Strauss.   

Abstract

We investigated the regulation of synthesis of low density lipoprotein (LDL) receptor in cultured luteinized human granulosa cells using a monoclonal antibody recognizing the human LDL receptor (IgG-C7). Cells cultured under serum-free conditions were treated with human chorionic gonadotropin (hCG) or 8-bromo-cAMP alone or in combination with aminoglutethimide (to block conversion of cholesterol to steroid hormones) and 5-cholesten-3 beta, 25-diol (25-hydroxycholesterol, a potent suppressor of LDL receptor expression in human fibroblasts) and pulse-labeled with [35S]methionine. A labeled protein immunoisolated with IgG-C7 was identified as the mature LDL receptor in 7.5% sodium dodecyl sulfate-polyacrylamide gels on the basis of an apparent molecular mass of 160 kDa, absence of the protein from immunoisolates prepared with a monoclonal antibody against an irrelevant antigen, and an apparent decrease in molecular weight of the mature receptor upon treatment with neuraminidase or electrophoresis under nonreducing conditions. hCG and 8-bromo-cAMP consistently increased the incorporation of radioactivity into the mature LDL receptor by 2-6-fold. The effect of hCG on LDL receptor synthesis was observed with as little as 10 mIU of hCG/ml and was apparent within 2 h of addition of the hormone. A combination of 25-hydroxycholesterol and aminoglutethimide resulted in a 60% suppression of label incorporation into mature LDL receptor compared to untreated cells. This would suggest some regulation of LDL receptor synthesis by negative feedback of sterol. However, both hCG and 8-bromo-cAMP increased label incorporation into the LDL receptor in the face of these agents. We conclude that in human granulosa cells, hCG, through the intermediacy of cAMP, rapidly increases LDL receptor synthesis by a mechanism which is, at least in part, independent of alterations in cellular cholesterol balance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055779

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Local role of progesterone in the ovary during the periovulatory interval.

Authors:  Charles L Chaffin; Richard L Stouffer
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Induction of high-density-lipoprotein receptors in rat corpus luteum by human choriogonadotropin. Evidence of protein synthesis de novo.

Authors:  D K Ghosh; K M Menon
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

3.  Regulation of bradykinin receptor level by cholera toxin, pertussis toxin and forskolin in cultured human fibroblasts.

Authors:  B G Etscheid; P H Ko; M L Villereal
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

4.  Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.

Authors:  J L Ellsworth; C Chandrasekaran; A D Cooper
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

5.  Regulation of low density lipoprotein receptor mRNA levels by estradiol 17beta and chorionic gonadotropin in human placenta.

Authors:  Y G Shanker; U P Shetty; A J Rao
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

6.  Expression of scavenger receptor-BI and low-density lipoprotein receptor and differential use of lipoproteins to support early steroidogenesis in luteinizing macaque granulosa cells.

Authors:  Mary Cherian-Shaw; Muraly Puttabyatappa; Erin Greason; Annabelle Rodriguez; Catherine A VandeVoort; Charles L Chaffin
Journal:  Endocrinology       Date:  2008-10-01       Impact factor: 4.736

7.  Cyclic AMP stimulates the synthesis and function of the low-density lipoprotein receptor in human vascular smooth-muscle cells and fibroblasts.

Authors:  B Middleton; A Middleton
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.